Brandywine Global Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-128,267
| Closed | -$23.6M | – | 746 |
|
|
2021
Q2 | $23.6M | Sell |
128,267
-176,462
| -58% | -$32.4M | 0.17% | 147 |
|
|
2021
Q1 | $46.6M | Sell |
304,729
-76,856
| -20% | -$11.8M | 0.35% | 71 |
|
|
2020
Q4 | $59.6M | Buy |
381,585
+10,445
| +3% | +$1.63M | 0.5% | 46 |
|
|
2020
Q3 | $42.5M | Sell |
371,140
-3,966
| -1% | -$454K | 0.42% | 62 |
|
|
2020
Q2 | $42.1M | Buy |
375,106
+182,569
| +95% | +$20.5M | 0.43% | 54 |
|
|
2020
Q1 | $17.3M | Buy |
+192,537
| New | +$17.3M | 0.21% | 109 |
|